Interferon-alpha (IFN-α) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway

被引:0
|
作者
Kaser, A [1 ]
Enrich, B [1 ]
Ludwiczek, O [1 ]
Vogel, W [1 ]
Tilg, H [1 ]
机构
[1] Univ Innsbruck Hosp, Dept Med, Div Gastroenterol & Hepatol, A-6020 Innsbruck, Austria
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1999年 / 118卷 / 01期
关键词
interferon-alpha; hepatitis C infection; cytotoxicity; perforin; Fas ligand;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cell-mediated cytotoxicity is exerted via perforin and Fas ligand (FasL). We have recently shown that IFN-alpha up-regulates Fast expression in T cells isolated from healthy volunteers and augments activation-induced T cell death. Since the Fas/FasL system is implicated in the pathogenesis of hepatic failure and both molecules have been shown to be up-regulated in hepatitis C virus (HCV) infection, we studied whether cytotoxicity via the Fast system is enhanced by IFN-alpha and therefore could contribute to hepatic injury. We investigated Fast and perforin expression in peripheral blood mononuclear cells (PBMC) derived from HCV+ donors by Northern analysis and soluble Fast synthesis by ELISA. Natural killer (NK) cell and cytotoxic T lymphocyte (CTL) cytotoxicity was studied by Cr-51-release assays. IFN-alpha up-regulates Fast mRNA and protein synthesis in mitogen-activated PBMC of HCV+ individuals, as previously found in healthy subjects. Stimulation with IFN-alpha increases perforin mRNA levels in PBMC. In NK cytotoxicity assays, the enhancement of cytotoxicity by IFN-alpha is mainly due to the perforin pathway, while the Fast pathway plays only a minor role. In CTL cytotoxicity experiments neither the Fast nor the perforin pathway is further enhanced by IFN-alpha. Our data suggest that upregulation of perforin by IFN-alpha results in elevated cytotoxicity, suggesting that IFN-alpha might support elimination of virally infected cells via this pathway. In contrast, the major effect of IFN-alpha on the Fas/FasL system might be the enhanced elimination of activated T cells as a means of finally limiting a T cell response.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 50 条
  • [31] IRON AND RESPONSE TO INTERFERON-ALPHA IN CHRONIC HEPATITIS-C
    FARGION, S
    CARAZZONE, A
    MOLTENI, V
    BOLDORINI, R
    SAMPIETRO, M
    FRACANZANI, AL
    DALBA, R
    RONCHI, G
    PIPERNO, A
    FIORELLI, G
    HEPATOLOGY, 1995, 22 (04) : 1234 - 1234
  • [32] Treatment of children with chronic hepatitis C with recombinant interferon-alpha
    Lacaille, F
    Micali, N
    Lachaux, A
    Morali, A
    Sarles, J
    Rieu, D
    Chouraqui, JP
    Maurage, C
    Gottrand, F
    ARCHIVES DE PEDIATRIE, 2002, 9 (03): : 339 - 340
  • [33] Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver
    Fukuda, R
    Ishimura, N
    Kushiyama, Y
    Moriyama, N
    Ishihara, S
    Nagasawa, S
    Miyake, T
    Niigaki, M
    Satoh, S
    Sakai, S
    Akagi, S
    Watanabe, M
    Fukumoto, S
    JOURNAL OF HEPATOLOGY, 1997, 26 (03) : 455 - 461
  • [34] CHRONIC HEPATITIS-B VIRUS-INFECTION AND INTERFERON-ALPHA
    GOESER, T
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (10) : 1793 - 1794
  • [35] Development of Systemic Lupus Erythematosus Following Interferon-Alpha Therapy for Chronic Hepatitis C Infection
    Rehman, Khalil
    Khokhar, Omar
    Khokhar, Nasir
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S143 - S143
  • [36] Intravenous interferon-alpha treatment of mixed cryoglobulinemia associated with chronic hepatitis C virus infection
    Zeller, V
    Cohen, P
    Nguyen, QT
    Lebon, P
    Dziri, S
    Ferrière, F
    Dény, P
    Guillevin, L
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (04) : 573 - 574
  • [37] Effect of therapy with interferon-alpha and pegylated interferon-alpha on platelet plug formation in patients with chronic hepatitis C
    Homoncik, M
    Jessner, W
    Sieghardt, W
    Gangl, A
    Ferenci, P
    Peck-Radosavljevic, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 145 - 145
  • [38] Chronic hepatitis-C infection, interferon-alpha treatment and peripheral serotonergic dysfunction.
    Schwaiger, M
    Pich, M
    Franke, L
    van Bömmel, F
    Berg, T
    Schaefer, M
    HEPATOLOGY, 2003, 38 (04) : 300A - 301A
  • [39] Alpha-interferon (IFN-α) treatment of chronic hepatitis C:: analysis of some predictive factors for the response
    Malaguarnera, M
    Di Fazio, I
    Trovato, BA
    Pistone, G
    Mazzoleni, G
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2001, 39 (06) : 239 - 245
  • [40] Treatment of chronic hepatitis C in dialysis patients and renal transplant recipients: Clinical experience of interferon-alpha (IFN).
    Kim, YO
    Kim, YS
    Chang, YS
    Bang, BK
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0911 - A0911